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The significance of allergen-specific IgE as marker for 
severity of atopic dermatitis is controversial. The aim of 
this study was to determine the frequency of IgE-media-
ted sensitisation to food and environmental allergens in 
132 children and 67 adults with atopic dermatitis, and its 
correlation to severity of atopic dermatitis (SCORAD). 
Total IgE was elevated (> 100 kU/l) in 79.7% of adults 
and 46.8% of children. Sensitisation frequencies to aller-
gens, particularly microbial allergens, were up to 10-fold 
higher in adults compared to children. Severity of atopic 
dermatitis correlated with elevated total IgE in adults 
(r = 0.549, p < 0.001) and children (r = 0.344, p = 0.005) 
and with Malassezia spp.-specific IgE in adults (r = 0.429, 
p = 0.007). Total IgE is a marker for severe atopic derma-
titis in both age groups. Malassezia spp.-specific IgE is an 
important allergen-specific marker for severity of atopic 
dermatitis in adults. Key words: Malassezia spp.; atopic 
dermatitis; allergen-specific IgE; SCORAD.
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Atopic dermatitis (AD) is a chronic fluctuating, in-
flammatory skin disease with an onset usually in early 
childhood (1). Within a few years, 30–60% of children 
develop atopic diseases of other organ systems, such as 
the lungs, the gastrointestinal tract, the respiratory tract, 
or the conjunctives; a sequence referred to as ‘atopic 
march’ (2). Allergens are supposed to play a role in the 
development of AD, because the impaired skin barrier 
in AD patients facilitates the allergen penetration th-
rough the skin and their subsequent recognition by the 
immune system. This results in an enhanced release of 
cytokines (interleukin (IL)-1b, IL-4, IL-5, IL-13, IL-18), 
inflammasome activation, and increased production of 
immunoglobulin E (IgE) (3, 4). Recent findings seem to 
substantiate the pathogenic role of IgE in AD owing to 
activation of the high-affinity Fce-receptor 1 on dendritic 
cells, activation of T cells, antigen-presenting cells and 
keratinocytes, and induction of histamine release with 
initiation of the itch-scratch-cycle (1, 5). Accordingly, 
some studies show a significant correlation between total 
IgE levels and the severity of AD (6). 
However, the correlation between allergen-specific 
IgE and AD severity is less clear and it is controversial 
whether IgE-mediated sensitisation to allergens plays 
a major role in AD (4). For example, about 50% of 
children with AD do not have elevated total IgE or 
any allergen-specific IgE sensitisation within the first 
2 years of age (7, 8), i.e. an age at which at least 60% 
of AD cases start (1). Also, 12–37% of adults with 
manifested AD do not have elevated IgE serum levels, 
depending on the geographic region (9, 10). Further-
more, symptoms in patients with very high IgE levels 
do not necessarily improve after treatment with anti-IgE 
antibodies (11). Therefore, we conducted this study to 
elucidate the role of IgE-mediated sensitisation to al-
lergens as serological marker for the severity of AD. We 
correlated the levels of total IgE and allergen-specific 
IgE against common food- and environmental allergens 
to the severity of AD in adults and children.
MATERIAL AND METHODS
Patients
This study was approved by the ethical committee of the 
University Hospital Schleswig Holstein, all patients/parents 
of affected children gave informed consent to participate. We 
assessed 199 patients (132 children, 67 adults) with AD seen at 
the Department of Dermatology, University Hospital Schleswig 
Holstein, Campus Kiel, Germany. The diagnosis of AD was 
confirmed by a board-certified dermatologist according to 
the criteria of Hanifin & Rajka (12), by the patient’s history 
and histopathology in ambiguous cases. Clinical parameters 
of patients including age, gender, and severity of eczema, as 
well as the status of filaggrin mutations were retrospectively 
obtained from patient files. Scoring of AD severity and blood 
sampling to determine IgE levels were performed at the same 
visit. At this visit patients did not receive any treatment other 
than emollients in some cases.
Assessment of atopic dermatitis severity
The severity of AD was assessed using SCORing Atopic Der-
matitis (SCORAD) index. This score considered (i) the extent 
of atopic eczema; (ii) the intensity of eczema, i.e. redness, swel-
ling, oozing, scratch marks, lichenification, and dryness; and 
(iii) subjective symptoms of AD patients including itching and 
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sleeplessness. A SCORAD < 25 indicated mild AD, a SCORAD 
between 25 and 50 indicated moderate AD, and a SCORAD 
> 50 (with a maximum index of 103) indicated severe AD (13). 
Testing of IgE antibodies
Serum samples from patients were collected during visits and 
stored at –30°C until analysis. All samples were analysed 
together for the presence of total IgE antibodies and allergen-
specific IgE antibodies using ImmunoCAP, a fluorescence 
enzyme immunosorbent assay, according to the manufacturer’s 
instructions (Phadia, Freiburg, Germany). The following aller-
gen-specific IgE antibodies were analysed: (i) food allergens: 
screening with multitest (ImmunoCAP code fx5, containing 
egg white, cow’s milk, cod, wheat, peanut, soybean); (ii) envi-
ronmental allergens: screening with multitest (sx1, containing 
Dermatophagoides pteronyssinus, cat dander, dog dander, timo-
thy grass, cultivated rye, Cladosporium herbarum, birch pollen, 
mugwort), birch pollen (t3), hazel pollen (t4), D. pteronyssinus 
(d1), D. farinae (d2), cat dander (e1), dog dander (e5), Malas-
sezia spp. (m70), Alternaria alternata (m6), Candida albicans 
(m5), C. herbarum (m2), and S. aureus enterotoxin A (m80). 
IgE antibodies specific to fungal allergens and staphylococcal 
enterotoxin A were analysed at the Allergy Unit, Department 
of Dermatology zurich, Switzerland. The other IgE antibodies 
were analysed at the Department of Dermatology in Kiel, Ger-
many. An ImmunoCAP class ≥ 2 (> 0.70 ku/l) was considered 
to demonstrate sensitisation to the respective antigen.
Statistics
Patients were allocated to 2 groups according their age: (i) 
children, 0–6 years of age, and (ii) adults, > 18 years of age. The 
results of IgE analysis (total and specific IgE) were matched with 
patient-related parameters (gender, age, head–neck type eczema, 
SCORAD, filaggrin mutation) in a database where patients were 
identifiable by number and initials. After descriptive statistics, 
a Gaussian distribution of scale variables was excluded by 
Kolmogorow-Smirnow and Shapiro-Wilk tests. Correlations bet-
ween SCORAD and parameters were analysed by Spearman-Rho 
(age, total IgE, specific IgE) and Kendall-Tau-b tests (specific 
IgE). For allergen-specific IgE antibodies, only p-values ≤ 0.05 
in both Spearman-Rho and Kendall Tau-b test were considered 
to be significant. Correlations between head–neck type AD and 
age, gender, total IgE and Malassezia spp.-specific IgE were 
calculated by Chi-square-test or Mann-Whitney-test. p-values 
≤ 0.05 (2-sided) were considered to be significant.
RESuLTS
Patients
The clinical characteristics of patients in both age 
groups are summarised in Table I. Briefly, 132 children 
between 9 months and 6 years of age and 67 adults 
between 19 and 51 years of age were investigated in 
our study. The severity of eczema was comparable in 
both age groups (p = 0.32). The majority of childhood 
and adult patients was diagnosed with mild to moderate 
eczema, reflected by a median SCORAD of 26 and 
25, respectively. An elevated concentration of total 
serum IgE (> 100 ku/l) was found more frequently in 
adults than in children (p = 0.018). The level of total 
IgE increased with the age of children (p = 0.011) but 
not with that of adults (p = 0.79) (data not shown). A 
similar ratio of patients in both age groups had AD of 
the head–neck type.
Correlation between clinical parameter and IgE-
mediated sensitisation
Sensitisation to Malassezia spp. correlated with a hig-
her SCORAD in adults (p = 0.007, r = 0.429) but not 
in children (Table II). Higher total IgE was a marker 
for more severe AD in adults (p<0.001, r = 0.549) 
Table I. Characteristics of study patients
Children 
n = 132
Adults 
 n = 67
Age, years, median (range) 3.4 (0.76–6.1) 27 (19–51)
Male:Female 82:50 30:37
SCORAD, median (range) 26 (6.0–78.5) 25 (3.5–64.5)
Categorised SCORAD, patients, %
  < 25 (Mild atopic dermatitis) 
  25–50 (Moderate atopic dermatitis)
  > 50 (Severe atopic dermatitis)
39.1
45
15.9
43.2
47.7
9.1
Head-neck type eczema, % 69 62
Total serum IgE elevated (> 100 ku/l), % 46.8 79.7*
*p = 0.018.
Table II. Correlation between total IgE or allergen-specific IgE and severity of atopic dermatitis (SCORAD) in children and adults
Children Adults
Allergen Patients, n
Correlation 
coefficienta p-value Patients, n
Correlation 
coefficienta p-value
Total IgE 65 0.34 0.005 41 0.55 < 0.001
Birch pollen 19 0.45 0.06 18 –0.02 0.95
Hazel pollen 15 –0.03 0.92 19 0.38 0.06
D. pteronyssinus 35 0.05 0.78 23 0.29 0.18
D. farinae 17 –0.06 0.83 13 0.29 0.34
Cat dander 28 0.29 0.13 27 0.32 0.1
Dog dander 24 0.18 0.40 23 0.33 0.75
Malassezia spp. 54 0.28 0.07 38 0.43 0.007
A. alternata 54 0.20 0.15 39 0.14 0.39
C. albicans 54 –0.13 0.34 38 0.25 0.14
C. herbarum 54 0.16 0.26 38 0.09 0.59
S. aureus enterotoxin A 20 –0.09 0.70 28 0.32 0.1
aCorrelation coefficient between severity of atopic dermatitis and total IgE or antigen-specific IgE levels as determined by Spearman-Rho.
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and in children (p = 0.005, r = 0.344). None of the 
other allergen-specific IgE antibodies correlated with 
SCORAD in adults or children (Table II). Patient age 
or gender and the presence of head–neck type AD did 
not correlate with the severity of disease in both age 
groups. Interestingly, the head–neck type of AD did 
not correlate with IgE specific to Malassezia spp. in 
either age group (children p = 0.28, adults p = 0.1) or 
with age, gender, and total serum IgE (data not shown).
Sensitisation to allergens
Except for Sx1 multitest and birch pollen, adults were 
more frequently sensitised to allergens than children 
(Fig. 1). The sensitisation frequency to food and most 
of the environmental allergens in adults was at least 
2-fold higher compared to children; those for microbial 
allergens was 5 to 10-fold higher in adults compared to 
children. Among fungal allergens, sensitisation to Ma-
lassezia spp. was the highest in both age groups, while 
sensitisation rates for C. albicans and C. herbarum were 
lower (Fig. 1). In both age groups, a higher Malassezia 
spp.-specific IgE titre positively correlated with a hig-
her total IgE titre (adults: p < 0.001, r = 0.67; children: 
p < 0.001, r = 0.41; data not shown). In addition to fungi, 
we analysed sensitisation against the enterotoxin A of S. 
aureus, a common skin pathogen in AD patients. Similar 
to fungal allergens, adults were more frequently sensiti-
zed to S. aureus enterotoxin A than children.
Adults also had higher titres of allergen-specific IgE to 
microbial allergens than children (Fig. 2). For example, 
the highest ImmunoCAP class for Malassezia spp. in 
adults was 6, found in 33% of sensitised adults, and for 
A. alternata it was 5, found in 6% of sensitised adults. 
In the children’s group, only a single patient had an Im-
munoCAP class of 5 for C. herbarum, whereas all other 
sensitised children had a maximum ImmunoCAP class 
of 2 or 3 for any microbial allergen tested. In contrast to 
fungal allergens, the maximum ImmunoCAP class for S. 
aureus enterotoxin A remained low in both age groups, 
with a highest ImmunoCAP of 2 in children and of 3 in 
adults. These findings of a higher sensitisation frequency 
and higher allergen-specific IgE titres against microbial 
allergens in adults indicate that sensitisation to these al-
lergens occurs predominantly in adulthood.
DISCuSSION
We assessed the IgE-mediated sensitisation to food- and 
environmental allergens in 132 children and 67 adults 
with AD and correlated these data with disease severity 
(SCORAD). In accordance with previous studies, high er 
total IgE was a marker for more severe eczema in both 
age groups (6, 14), and Malassezia spp.-specific IgE 
was the only specific IgE positively correlating to AD 
severity in adults in the present study. Thus, this study 
Fig. 1. Proportion of adults (black bars) and children (white bars) with 
AD tested positive for allergen-specific IgE. The x-axis indicates the tested 
allergens. The y-axis indicates the percentage of positive patients. The labels 
above the bars indicate the percentage of positive patients.
Fig. 2. Percentage of ImmunoCAP classes of allergen-specific IgE in adults (A) and children (B) with atopic dermatitis. An ImmunoCAP class ≥ 2 was 
considered to be positive.
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identifies Malassezia spp.-specific IgE as an important 
allergen-specific marker for AD severity in Caucasian 
adults for the first time. Previous findings on the cor-
relation between the sensitisation to microbial allergens 
and severity of AD are ambiguous. AD patients with 
severe eczema and/or higher total IgE levels appear 
to be frequently sensitised to microbial antigens, with 
40% of these children and 72% of these adults having 
Malassezia spp.-specific IgE, and 60% of children 
and 82% of adults having IgE specific to various stap-
hylococcal superantigens (15, 16). However, a clear 
correlation between AD severity and IgE specific to a 
distinct microbial allergen is rarely described. Whereas 
A. alternata and C. herbarum do not correlate with 
the severity of AD (17), Malassezia spp.-specific IgE 
correlated with the severity of disease in 61 adult AD 
patients from Japan (18). Another study on 619 adult 
patients from Sweden showed a correlation between 
the severity of AD and the combined IgE sensitisation 
to dust mites and yeasts such as Malassezia spp. and 
C. albicans (19). 
The significant role of Malassezia spp. in adult AD 
patients is substantiated by recent findings. Firstly, DNA 
sequencing-based analyses have confirmed that Malas-
sezia spp. are the predominant fungal genus on adult 
human skin, also on body sites that are clinically affected 
in AD (20). Accordingly, Malassezia spp. specific IgE 
were the most abundant microbe-specific IgE found in 
our adult patients. Secondly, nanovesicles and proteins 
from skin-colonising Malassezia spp. can induce the 
release of pro-inflammatory cytokines and histamine, 
which may contribute to the pathogenesis of AD (21, 
22). Thirdly, Malassezia spp. antigens such as manganese 
superoxide dismutase or thioredoxin induce autoreactive 
T cells that further react to the human analogues of the 
fungal enzymes, inducing pro-inflammatory stimuli 
that continues independently from Malassezia spp. (23, 
24). This might explain why the efficacy of antimycotic 
treatment of AD is ambiguous (25, 26), because the auto-
immunologic mechanisms perpetuate even if the yeasts 
are eradicated from the skin. Therefore, we speculate that 
the presence of Malassezia spp.-specific IgE antibodies 
in adult AD patients does not predict the efficacy of 
antimycotic treatment but is a marker for a more severe 
and perhaps persistent AD.
Despite the high percentage of dust mite sensitisation 
in our patients we did not find a correlation between 
dust mite-specific IgE and severity of AD, presumably 
because we did not stratify our patients according to dust 
mite allergen burden, which correlates with AD severity 
(27). However, a correlation between AD severity and 
dust mite-specific IgE was shown in a cross-sectional 
study on 2,200 East German schoolchildren (28), and 
recent experiments demonstrated that epicutaneous app-
lication of dust mites on non-lesional skin of AD patients 
induces thymic stromal lymphopoietin and CCL17, 
which are important triggers for an AD characteristic 
immune response (29).The sensitisation frequency to 
microbial antigens in the children of our study was low, 
it is therefore not surprising that we did not identify a 
correlation between AD severity and sensitisation to 
Malassezia spp. or any other microbial allergen in this 
age group. The children in our study tended to be younger 
(maximum 6 years of age) than those in previous studies 
(maximum 17 years of age), in which higher frequencies 
of elevated Malassezia spp.-specific IgE were found, 
ranging from 5 to 17% (14, 30, 31). One reason for the 
low frequency of Malassezia spp. sensitisation in the 
young children of our study compared to older children 
and adults in previous studies might be the age-dependent 
increase of skin sebum lipids as a prerequisite for skin 
colonisation with most Malassezia spp. in adolescence 
and adulthood (26). Furthermore, the longer history of 
AD of older age groups and larger extend of eczema cor-
relate with a higher probability of allergen sensitisation 
over time (6, 31, 32). This might explain why a previous 
investigation on AD children up to 16 years of age found 
higher frequencies of Malassezia spp. sensitisation with 
already a (weak) correlation to severity of AD (14). The 
IgE reactivity also to other allergens appears to correlate 
with age. For example, children at the age of 6 month 
are more frequently sensitised to food allergens than to 
inhalant allergens (35% vs. 18%), with a reverse ratio at 
the age of 5 years (18% vs. 66%) (33), and the sensitisa-
tion frequencies to microbial allergens increase with the 
age of children (34).
The higher frequency of allergen-specific IgE in 
adults than in children seen in this study is also des-
cribed by others, particularly for Malassezia spp. to 
which 5–17% of children (14, 30, 31) and 29–65% of 
adults (30, 35, 36) with AD develop specific IgE. The 
sensitisation frequencies of 33–95% for C. albicans in 
children and adults described earlier (34, 37, 38) are 
considerably higher than in the present study, but might 
be in part explained by ethnically and possibly socio-
economically differences in the study populations. The 
previously reported sensitisation frequencies to various 
superantigens of S. aureus are higher in adults (80%) 
than in children (60%) (15, 16), and considerably 
higher than in the present study for both age groups. 
This might be due to the use of only S. aureus entero-
toxin A in this study. We found a considerably higher 
frequency of food allergen-specific IgE in adults than 
in children (80.4% vs. 42.2%). However, our results are 
difficult to compare with previous findings, since we 
used the fx5 food allergen screening test that detects 
IgE specific to egg white, cow’s milk, cod, wheat, pe-
anut, or soybean, without the ability to break down the 
result to the particular test allergen. Previous studies 
have shown that egg white, peanut and cow’s milk 
are the major food allergens in children with AD, and 
IgE-specific sensitisation to these allergens are found 
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in 25–54%, 7–45%, and 18–48% of patients, respec-
tively. Sensitisation rates vary by geographic region, 
presumably due to dietary factors (8). By the age of 
16 years, egg and milk allergy resolves in 68% and 
79% of children, and adults are more often sensitized 
to peanut, shellfish and fish (39).
The present study has several limitations. Firstly, 
we used the m70 antigen to detect Malassezia spp.-
specific IgE. This antigen represents the species M. 
sympodialis and is sensitive to other relevant Malas-
sezia species. However, patients with a negative m70 
test result may have IgE antibodies specific to other 
Malassezia species such as M. globosa and M. pachy-
dermatis. Therefore, the use of only m70 antigen may 
not detect all patients sensitised to Malassezia spp. 
(40). Secondly, sensitisation to S. aureus was only 
tested with the antigen m80, representing the S. aureus 
enterotoxin A. Similar to the problem by using only 
m70 antigen for Malassezia spp., the use of only m80 
antigen may miss sensitisations to other relevant S. 
aureus superantigens such as the enteroxins B–D and 
toxic shock syndrome toxin. Thirdly, we tested food 
allergen-specific IgE with the fx5 screening test. Be-
cause this test does not allow to breakdown the results 
to the particular test antigen it was not used to assess 
the correlation between food allergen-specific IgE 
and AD severity. Fourthly, we included only children 
between the age of 0–6 years because AD is highly 
prevalent in this age group and a large number of 
patients was therefore available for inclusion into the 
present study. Hence this study lacks information on 
the correlation between allergen-specific IgE and AD 
severity in older children and adolescents.
In conclusion, Malassezia spp.-specific IgE cor-
relates with the severity of AD in adults. The missing 
correlation in children is due to the low frequency of 
allergen sensitisation in this age group. Based on the 
supposed elucidation of pro-inflammatory autoreactive 
mechanisms by Malassezia spp. proteins, we speculate 
that Malassezia spp.-specific IgEs are only a marker for 
a more severe and perhaps a more prolonged disease, 
but they do not necessarily indicate the necessity of an 
antimycotic therapy.
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